Proper Name: Botulism Immune Globulin Intravenous (Human)
Manufacturer: California Department of Health Services, License #1622
- Treatment of infant botulism caused by type A or type B Clostridium botulinum
Dosing Decrease to 1.0 mL/kg (50 mg/kg) and Expiration Date Extension for Botulism Immune Globulin Intravenous (Human) (BIG-IV) Lot 5 to March 02, 2015. Dear Healthcare Provider:IMPORTANT CHANGE IN BabyBIG® PRESCRIBING INFORMATION(PDF - 539KB)
Date: September 23, 2013
FDA Online Label Repository
Search this database for drug labeling and other information. The content has not been altered or verified by the FDA and may not be the labeling on currently distributed products or identical to the labeling that is approved.